Rik J. Verheijden - Dissemin

Language
Login

All papers authored by Rik J. Verheijden

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2021 Karijn P. M. Suijkerbuijk

ORCID

, Rik J. Verheijden

ORCID

TNF inhibition for immune checkpoint inhibitor-induced irAEs: the jury is still out

Upload

This paper is made freely available by the publisher.

Josefien W. Hommes, Rik J. Verheijden

ORCID

, Karijn P. M. Suijkerbuijk

ORCID

, Dörte Hamann

Biomarkers of Checkpoint Inhibitor Induced Immune-Related Adverse Events—A Comprehensive Review

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2020 M. Schuiveling, E. H. J. Tonk, R. J. Verheijden

ORCID

, K. P. M. Suijkerbuijk

ORCID

Hyperprogressive disease rarely occurs during checkpoint inhibitor treatment for advanced melanoma

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Karijn P. M. Suijkerbuijk

ORCID

, Ellen Kapiteijn, Rik J. Verheijden

ORCID

Management of Immune-Related Adverse Events Affecting Outcome in Patients Treated With Checkpoint Inhibitors

Upload

This paper was not found in any repository, but could be made available legally by the author.

Rik J. Verheijden

ORCID

, Anne M. May, Christian U. Blank, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Alfonsus J. M. van den Eertwegh, Jan Willem B. de Groot, Marye J. Boers-Sonderen, Jacobus J. M. van der Hoeven, Geke A. Hospers

ORCID

, Djura Piersma, Rozemarijn S. van Rijn, Albert J. ten Tije, Astrid A. M. van der Veldt, Gerard Vreugdenhil and 5 other authors

Association of Anti-TNF with Decreased Survival in Steroid Refractory Ipilimumab and Anti-PD1–Treated Patients in the Dutch Melanoma Treatment Registry

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Rik J. Verheijden

ORCID

, Anne M. May, Christian U. Blank

ORCID

, Astrid A. M. van der Veldt, Marye J. Boers-Sonderen, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Alfonsus J. M. van den Eertwegh, Jan Willem B. de Groot, Jacobus J. M. van der Hoeven, Geke A. P. Hospers, Djura Piersma, Rozemarijn S. van Rijn, Albert J. ten Tije, Gerard Vreugdenhil and 5 other authors

Lower risk of severe checkpoint inhibitor toxicity in more advanced disease

Upload

This paper was not found in any repository, but could be made available legally by the author.

2018 R. Verheijden

ORCID

, K. Suijkerbuijk

Baseline CRP predicts severe immune related adverse events

Upload

Missing publications? Search for publications with a matching author name.